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During the study, the doses were adjusted to reach this goal.
We deliberately did not choose a randomized placebo controlled trial but supplemented all VLBW infants in order to study our concept of individually adjusted supplements. This design would provide us with one group of infants who excrete Ca + Pi together with urine and a second group who would not. A better mineral accretion rate of the infants excreting Ca + Pi would support and equal mineralization in both groups would falsify our hypothesis.
Ca and Pi were measured by standard methods during the daily routine (25, 26) . The lower limits of the method for detecting Ca was 1.2 and 0.4 mmol/L, respectively, for Pi. The coefficient of variation was 2.3% for Ca and 4% for Pi. The study was approved by the Committee on Human Experimentation of the University of Ulm.
Photon absorption densitometry. BMC was measured in the middle of the right humerus at 3 (range, 2-6)-wk intervals by single photon absorption densitometry as described previously (24) . The coefficient of variation was 3%. BMC is best correlated with body weight (24) . The change in BMC, therefore, was related to the change in body weight (mg cm-'/lo0 g) over the same period.
Patients. All VLBW infants admitted to our unit were eligible for the study. Infants were excluded when they died or were transferred to other hospitals during the first 28 d. Seventy-four VLBW infants (birth weight, median 970 g, range 430-1.580; gestational age, median 28 wk, range 24-33) were supplemented with Ca and/or Pi (as planned) and observed for a total of 104 periods (median = 2 periods, range 1-5) of 3 wk (range 2-6). The wide range of observational periods resulted from the variation in birth weight and duration of stay in hospital. The bone mineral accretion rates during these intervals (mg cm-'/lo0 g weight gain) were grouped according to the type of Ca/Pi urinary excretion observed during these periods: group 1, periods when more than half of the urinary specimens contained both Ca P 1 . 2 mmol/L) and Pi (M.4 mmol/L); group 2, periods when fewer than half of the urinary specimens contained both Ca + Pi.
When data from more than one period was available in one infant, one period was randomly selected for data analysis and statistical comparison. Data were only selected from periods when the parenterally supplied amount of Ca/Pi contributed less than 10% of the total administered dose.
The infants were fed with their own mother's milk when available, this being individually substituted with Alfar6 (3-6 g/ dL, Nestlt. Munich, Germany) to provide enough energy and protein in case of low plasma amino acid concentrations (< 1800 ccmol/L). Otherwise, cow's milk-based, special care formulas (Meb, Milupa, Friedrichsdorf, Germany; Humana 0 Friihnahrung, Humana Milchwerke e. G., Herford, Germany) were used (Table 1 ). All infants received 1000 IU of vitamin D3 orally daily after the first week of life. Enteral feedings were started on the first day of life and complemented by parenteral nutrition during the first days.
Confirmative statistical analysis was limited to the evaluation
* MCT, medium-chain triglycerides.
of the hypothesized differences in BMA between group 1 and group 2 (Mann-Whitney test).
RESULTS
The amount of supplemented Ca and/or Pi was gradually increased until a low urinary excretion of both Ca + Pi was achieved. This goal was reached in only 30 of 74 studied periods (group 1). In this group, median bone mineral accretion was 5.1 mg cm-'/I00 g weight gain, which is equivalent to the intrauterine rate (4.5) (24) . During the 44 periods, when simultaneous excretion of both Ca + Pi was not observed in more than half of the urine samples (group 2), BMA was significantly lower (mean 2.4) than during periods when this goal was reached (group 1) (one-tailed probability; p = 0.0 12) ( Table 2) . BMA was proportional to the number of urine samples containing both Ca + Pi (Fig. 1) . The wide range of BMA in group I prompted us to look for factors that contribute to this variation. The BMC at the beginning of an observational period was significantly correlated with BMA during the next weeks; infants who had a BMC above the 50th percentile value for their body weight achieved only a low BMA or even lost bone mineral, whereas infants with low BMC yielded a more than average BMA (Fig. 2) . Further analysis revealed a coincidence of high BMA, a high percentage of Ca + Pi positive urine samples and a low mineral status at the beginning of an observational period (Fig. 2) .
DISCUSSION
The mineralization of skeletal tissue in vertebrate organisms is a complex and not completely understood process (27) (28) (29) (30) . The crystalline structure of apatite requires the presence of both Ca + Pi in sufficient concentrations to form new crystallites.
Conducive to the deposition of calcium phosphate minerals is an elevation of local Ca + Pi concentration (25) , but nothing is known about the plasma concentrations of either ion necessary to achieve the apatite accretion rate of the fetus in the preterm infant. In addition, what is a normal bone mineral accretion rate in VLBW infants? The only naturally provided yardstick for bone mineralization in preterm infants is the intrauterine bone mineral accretion rate during the same postmenstrual period. Intrauterine BMC is strongly and linearly related to body weight and, from cross-sectional data, the mineral accretion rate was calculated as 4.55 mg cm-'/lo0 g weight gain (24) .
Greer and co-workers tried to achieve intrauterine mineralization rate in preterm infants by feeding a special-care formula highly enriched with Ca (1400 mg/L) + Pi (750 mg/L) but then observed in some of their infants a zero rate or even a decrease in BMC (15) . These varying results are probably explained by the considerable variation of the, on average, low Ca net absorption from cow's milk-based formulas in preterm infants (3 1-40) . The enteral supplementation, therefore, should be given individually to prevent demineralization in insufficiently supplemented 4 Bone mineral status = BMC at the beginning of an observational period minus the 50th percentile value in newborn infants of the same body weight at birth. infants and also to avoid the potential risk of nephrocalcinosis through overdose. The individual measurement of enteral Ca net absorption is a time-consuming procedure, unsuitable for clinical routine. The easy-to-do measurement of Ca and Pi in urine spot specimens seemed to us to be a simple way of monitoring the supplementation. In VLBW infants fed every 2 to 3 h, we found that measurements of <1.2 mmol of Ca and <0.4 mmol of Pi, respectively (the lower limits of detectability with our method), 'n a spot urine specimen were representative for all spot urine specimens delivered over 24 h. We also observed, 1 d thereafter, a urinary excretion of Ca and/or Pi as a rapid response to sufficient supplementation. We therefore took the absence of Ca and/or Pi from the urine as a sign of Ca and/or Pi deficiency, which we then enterally and/or parenterally compensated for until low urinary concentration showed a slight surplus.
The positive correlation between the percentage of Ca + Pi positive urinary samples and the BMA rate and the significant difference in BMA between the infants who excreted Ca + Pi together in more than 50% or fewer than 50% of the measured urine samples supported our hypothesis that the supplementation of preterm infants with Ca and Pi to yield postnatally an intrauterine BMA can be monitored by measuring the urinary concentrations of both ions.
A high BMA was also correlated with a low BMC at the beginning of an observational period (Fig. 2) . A stepwise linear regression even revealed that the BMC at the beginning contributed more than the Ca + Pi excretion to the variance of BMA.
But this correlation makes sense only in connection with a simultaneous sufficient supplementation with minerals and the coincidence of high BMA rates, high Ca + Pi excretion rates and a low starting BMC can be easily explained by the design of our study. The supplements were increased so slowly that the simultaneous excretion of Ca + Pi was not achieved until a median postnatal age of 1 1 wk. During this long period the infants did not receive sufficient amounts of Ca + Pi to achieve the intrauterine BMA. In some infants the bones were even demineralized in order to have some material for the mineralization of the newly grown parts ofthe skeleton. But eventually the supplement met requirements and then the infants with the lowest BMC yielded the higher BMA, i.e. a catch-up mineralization took place.
The net absorption of Ca from cow's milk-based formulas is low in preterm infants, varies considerably interindividually and reaches only 50% at 60 d postnatal age (36) . Our findings are consistent with the concept of a maturation of Ca absorption. In group 1, the median dose of Ca required to yield a urinary excretion of Ca was 4.2 mmol/kg/d and varied considerably between 2.4 and 8.5. The median age was 11.1 wk. The infants in group 2, however, were younger (6.7 wk) and their Ca absorp-tion must have been lower than in group 1, because even a higher dose of Ca (5.6) did not reach the target of a continuous urinary excretion of Ca.
The gradual increase of supplementation was obviously too slow, because the simultaneous excretion of Ca + Pi in more than half of the urine specimens (group 1) was only achieved in 30 of 74 studied periods and not until a median postnatal age of 1 1 wk. Average daily Ca (Pi) accretion was calculated from the content of fetal bodies at different gestational ages as 3.2 (2.5) mmol/kg (22, 41-44). Assuming a rather good 50% Ca net absorption, the enterally fed preterm infant should receive a total of 6.4 mmol of Ca kg-l/d in order to meet the requirement at the beginning of supplementation. The Ca supplement required depends on the Ca-concentration of the type of milk provided. It should bring the milk Ca content up to 6.4 mmol/kg. In case of a continuing lack of urinary Ca excretion, the daily Ca dose should be increased each week by 2 mmol kg-'. Phosphorus supplementation ( 1-2 mmol/kg) is mainly necessary in the breast milk-fed infant. Special-care formulas for preterm infants are sufficiently enriched with phosphorus. The principle of Pi supplementation guided by urinary concentrations cannot be applied to infants with Pi-losing nephropathy. Here, Pi is excreted at low plasma Pi concentrations that do not allow normal mineralization (45) . The same could be true for Ca in infants receiving a long-term treatment with furosemide that impairs the tubular reabsorption of Ca.
The bone mineral accretion rate clearly correlated with the percentage of Ca + Pi-positive specimens and was highest in group 1. Confirming the wide variation of net Ca absorption we observed that a wide range of Ca was necessary to bring about slight urinary excretion (46). The daily doses of Ca + Pi were added to the total daily milk volume in order to provide Ca + Pi simultaneously and constantly, around the clock. By doing this, the increase in osmolarity of the milk was kept as low as possible. No cases of intestinal obstruction or necrotizing enterocolitis were observed. Ca added in large amounts to milk form insoluble Ca soaps and impair fat absorption, but a preliminary report showed the same weight in all infants independent of the amount of supplemented Ca (46).
Nephrocalcinosis and urolithiasis have been said to be a result of Ca/Pi supplementation but are not likely to occur when the dose is monitored individually and increased gradually until urinary excretion starts in low concentrations. Twenty-four s u p plemented infants were examined longitudinally for nephrocalcinosis by ultrasound. Only one infant, who had received longterm treatment with furosemide, developed nephrocalcinosis
(47).
We have presented evidence that our proposal offers a simple, effective and safe way of preventing bone demineralization in VLBW infants while taking into account individual needs and varying amounts of Ca and Pi in breast milk as well as formulas of differing compositions. However, although our study was prospectively designed and the gradually increased Ca/Pi supplements were administered as planned, we retrospectively classified the infants as group 1 and group 2. Therefore, a further prospective trial is needed to test our hypothesis. 
